Jose I. Santos
National Autonomous University of Mexico
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jose I. Santos.
Journal of Clinical Microbiology | 2006
Coralith García; Herbert L. DuPont; Kurt Z. Long; Jose I. Santos; GwangPyo Ko
ABSTRACT Sixty-three children in periurban Mexico City were examined for the occurrence of asymptomatic norovirus (NoV) infection from June to August 1998. NoV was detected in 48 of 161 stool specimens (29.8%), with 31 children (49.2%) having at least one positive stool. Asymptomatic NoV infection occurred commonly during summertime in a Mexican pediatric population.
Clinical Infectious Diseases | 2004
Dolores Alcantar-Curiel; Juan Carlos Tinoco; Catalina Gayosso; Angeles Carlos; Carlos Daza; Maria C. Perez-Prado; Lorena Salcido; Jose I. Santos; Celia Alpuche-Aranda
We describe the prevalence and molecular characteristics of extended-spectrum beta -lactamase (ESBL)-producing Klebsiella pneumoniae causing nosocomial bacteremia and urinary tract infections in a Mexican general hospital. We analyzed 82 episodes of bacteremia (approximately 60% of episodes) and urinary tract infection (approximately 40% of episodes) due to K. pneumoniae during a 23-month surveillance period. The neonatal intensive care unit accounted for 49% of all episodes. All strains were imipenem susceptible; 62.2% of the strains were resistant to ceftazidime, cefotaxime, and aztreonam; 69.5% were resistant to amikacin; 58.5% were resistant to gentamicin; and 7.3% were resistant to ciprofloxacin. All strains were associated with 28 pulsed-field gel electrophoresis patterns, and dissemination of 2 ceftazidime-resistant clones produced 44% of the cases. The ESBL phenotype in these clones was transferred by identical or highly related megaplasmids. The ESBL activity corresponded to SHV-5 and TLA-1. Cross-transmission of 2 ceftazidime-resistant clones and the horizontal spread of identical or highly related megaplasmids explain the high prevalence of ESBL phenotype in these infections.
Infection Control and Hospital Epidemiology | 2001
Gerardo Martinez-Aguilar; Celia Alpuche-Aranda; Carmen Anaya; Dolores Alcantar-Curiel; Catalina Gayosso; Carlos Daza; Cesar Mijares; Juan Carlos Tinoco; Jose I. Santos
We describe a case-control study of a small outbreak of nosocomial sepsis and pneumonia with high mortality due to clonal dissemination of a multiresistant Klebsiella pneumoniae in the neonatal intensive care unit of a Mexican institution. Our study helped to change nosocomial infection control policy in this hospital.
Vaccine | 2009
Pablo F. Belaunzarán-Zamudio; Miguel L. García-León; Rosa María Wong-Chew; Angelina Villasís-Keever; Jennifer Cuellar-Rodríguez; Juan L. Mosqueda-Gómez; Teresa Muñoz-Trejo; Kenia Escobedo; Jose I. Santos; Guillermo M. Ruiz-Palacios; Juan Sierra-Madero
OBJECTIVE The objective of the study was to evaluate the immune response to measles vaccine of HIV-infected adults in comparison to HIV non-infected adults. DESIGN We conducted a cross-sectional study to identify adults lacking measles antibodies. 26 HIV-infected patients and 22 controls found to be measles seronegative in the cross-sectional study, received the MMR vaccine. We prospectively followed patients and measured measles antibodies, and cellular proliferative responses against measles antigens. We registered all adverse events at baseline, 3 and 12 months after vaccination. METHODS We determined measles antibodies by ELISA and cellular proliferative response in PBMCs at baseline, and repeated measurements at 3 and 12 months after vaccination. RESULTS The humoral immune response to the vaccine between HIV-infected adults and the HIV-uninfected group was not statistically different at 3 months (81% vs. 86% respectively). One year after vaccination, a higher proportion of HIV-infected adults had lost measles antibodies in contrast to controls. The cellular response was not statistically different between the groups at baseline, 3 and 12 months after immunization despite the waning of antibodies at 12 months. No severe adverse events were observed. Most patients were receiving HAART and had a mean CD4+ cell count of 496 cells/mL. CONCLUSIONS The initial humoral immune response to measles vaccine was not different between HIV-infected adults and HIV-uninfected adults. However, HIV-infected adults have a rapid decline of measles antibodies despite their high CD4+ cell count and sustained cellular proliferative response.
Infection Control and Hospital Epidemiology | 2001
Artemio Gonzalez-Vertiz; Dolores Alcantar-Curiel; Marcela Cuauhtli; Carlos Daza; Catalina Gayosso; Graciela Solache; Cruz Horta; Francisco Mejia; Jose I. Santos; Celia Alpuche-Aranda
This article describes an outbreak of bloodstream infection due to clonal dissemination of multiresistant Klebsiella pneumoniae in a neonatal area, during August 1999, in Mexico City General Hospital. The intestinal tract was the likely reservoir, and intensification of Contact Precaution measures contained the outbreak.
American Journal of Human Genetics | 1998
José Faibes Lubianca Neto; Leonard Lu; Roland D. Eavey; Marco Antonio Macias Flores; Raul Martinez Caldera; Somkiat Sangwatanaroj; Jean-Jacques Schott; Barbara McDonough; Jose I. Santos; Christine E. Seidman; Jonathan G. Seidman
We report that the Bjornstad syndrome gene maps to chromosome 2q34-36. The clinical association of sensorineural hearing loss with pili torti (broken, twisted hairs) was described >30 years ago by Bjornstad; subsequently, several small families have been studied. We evaluated a large kindred with Bjornstad syndrome in which eight members inherited pili torti and prelingual sensorineural hearing loss as autosomal recessive traits. A genomewide search using polymorphic loci demonstrated linkage between the disease gene segregating in this kindred and D2S434 (maximum two-point LOD score = 4.98 at theta = 0). Haplotype analysis of recombination events located the disease gene in a 3-cM region between loci D2S1371 and D2S163. We speculate that intermediate filament and intermediate filament-associated proteins are good candidate genes for causing Bjornstad syndrome.
Journal of Nutrition | 2011
Kurt Z. Long; Coralith García; GwangPyo Ko; Jose I. Santos; Abdullah Al Mamun; Jorge L. Rosado; Herbert L. DuPont; Nanda Nathakumar
Vitamin A supplementation is associated with divergent clinical norovirus (NoV) outcomes in Mexican children. Fecal cytokine concentrations following NoV genogroup infections among 127 Mexican children 5-15 mo old enrolled in a randomized, double-blind, placebo-controlled, vitamin A supplementation trial were determined to clarify the role the gut immune response plays in these associations. Stools collected from supplemented children [20,000 IU retinol (3.3 IU = 1 μg retinol) for children < 12 mo of age; 45,000 iu for children ≥ 12 mo] or children in the placebo group were screened for NoV genogroups I (GI) and II (GII). Monocyte chemoattractant protein-1 (MCP-1), TNFα, IL-5, IL-6, IL-8, IL-4, IFNγ, and IL-10 fecal concentrations were also determined. Differences in cytokine levels between the 2 groups following GI and GII infections were determined using ordered logistic regression models. MCP-1 and IL-8 levels were greater among GI- and GII-infected children, respectively, compared with uninfected children, whereas IL-5 levels were greater following both genogroup infections. MCP-1, IL-8, and IL-6 fecal levels were reduced among supplemented children with GII-associated diarrhea compared with the placebo group. Vitamin A-supplemented, GII-infected children had reduced MCP-1 and TNFα levels compared with GII-infected children in the placebo group (P-interaction = 0.02 and 0.03, respectively). Supplemented children with GI-associated diarrhea had higher TNFα and IL-4 levels compared with children in the placebo group with diarrhea (P-interaction = 0.02 and 0.02, respectively). The divergent effects of supplementation on NoV outcomes may result from the different effects vitamin A has on the genogroup-specific immune responses.
European Journal of Clinical Nutrition | 2009
Jorge L. Rosado; Maria del Carmen Caamano; Yura Montoya; M de Lourdes Solano; Jose I. Santos; Kurt Z. Long
Background:The efficacy of micronutrient supplementation on growth may be modified by specific gastrointestinal parasite infectionsMethods:We carried out a double-blind placebo-controlled trial to evaluate the effect of vitamin A and zinc supplementation on gastro-intestinal pathogen infections and growth among 584 infants in Mexico City. Children aged 5–15 months were assigned to receive either a vitamin A supplement every 2 months (20 000 IU of retinol for infants ⩽; 1 year or 45 000 IU for infants >1 year), a daily supplement of 20 mg of zinc, a combined vitamin A–zinc supplement or a placebo, and were followed up for 1 year. Weight and length were measured once a month and morbidity histories were recorded twice a week for 12 months. Monthly stool samples were screened for Giardia duodenalis, Ascaris lumbricoides and Entamoeba spp. Growth velocity slopes, generated from the linear regression of individual child length, and height-for-age z-scores on time were analyzed as end points in regression models, adjusting for the presence of parasite infectionsResults:The main effect of vitamin A supplementation was in height improvement (P<0.05), and was only found in the model evaluating infants with any parasite. There was an interaction effect of slower growth (P<0.05) found in infants infected with any parasite and supplemented with vitamin A in slower growth (P<0.05). In addition, the interaction of zinc supplementation and Giardia duodenalis or A. lumbricoides was associated with reduced growth (P<0.05).Conclusion:Gastro-intestinal parasite infections may modify the effect that zinc or vitamin A supplementation has on childhood growth.
Acta Tropica | 2017
Jose I. Santos; Bruno M. Meneses
The Zika virus, one of the new epidemic diseases, is reported to have affected millions of people in the past year. The suitable climate conditions of the areas where Zika virus has been reported, especially in areas with a high population density, are the main cause of the current outbreak and spread of the disease. Indeed, the suitable climatic conditions of certain territories constitute perfect breading nest for the propagation and outbreak of worldwide diseases. The main objective of this research is to analyze the global distribution and predicted areas of both mosquitoes Ae. aegypti and Ae. albopictus which are the main vectors of Zika virus. Physical (SRTM) and climatic variables (WorldClim) were used to obtain the susceptibility maps based on the optimum conditions for the development of these mosquitoes. The susceptibility model was developed using a Species Distribution Model - correlative model, namely the Maximum Entropy, that used as input the spatial references of both vectors (Dryad Digital Repository). The results show the most important classes of each independent variable used in assessing the presence of each species of mosquitoes and the areas susceptible to the presence of these vector species. It turns out that Ae. aegypti has greater global dispersion than the Ae. albopictus specie, although two common regions stand out as the most prone to the presence of both mosquito species (tropical and subtropical zones). The crossing of these areas of greater susceptibility with areas of greater population density (e.g. India, China, Se of USA and Brazil) shows some agreement, and these areas stand out due to the presence of several records of Zika virus (HealthMap Project). In this sense, through the intersection of susceptibility and human exposure the areas with increased risk of development and spread of Zika virus are pinpointed, suggesting that there may be a new outbreak of this virus in these places, if preventive measures are not adopted.
Journal of Clinical Microbiology | 2007
Devasena Gnanashanmugam; Meira S. Falkovitz-Halpern; Anthony Dodge; Melanie Fang; Lisa J. Wong; Melissa Esparza; Rebecca Hammon; Enrique E. Rivas-Merelles; Jose I. Santos; Yvonne Maldonado
ABSTRACT A uracil-to-cytosine mutation at nucleotide position 472 of oral poliovirus vaccine type 3 (OPV3) contributes to the development of vaccine-associated paralytic poliomyelitis (VAPP). To analyze OPV3 shedding patterns, we previously used the multistep method of mutant analysis by PCR and enzyme cleavage (MAPREC). This involves conventional reverse transcription-PCR to detect OPV3, followed by a restriction digest to quantify position 472 reversion. Real-time PCR detects and quantifies nucleic acid as PCR occurs and avoids postreaction processing. The goal of this study was to compare a real-time PCR method to MAPREC. Seventy-three stool samples from Mexican OPV recipients underwent the reverse transcription-PCR step of MAPREC and real-time PCR. Real-time PCR identified 23% more OPV3-positive samples than conventional reverse transcription-PCR. When reversion was compared, the revertant proportion (RP), defined as the percentage of revertants in a sample, differed by ≤10% in 21/25 (84%) samples. The four samples differing by >10% were obtained within 5 days of OPV administration. The real-time PCR assay identified samples with an RP of ≥85% with 94% sensitivity and 86% specificity compared to MAPREC. The mean difference in RP between the two methods was 3.6% (95% confidence interval, −0.3 to 7.5%). Real-time PCR methods reliably detect OPV3, and reversion estimates correlate more consistently with MAPREC when OPV3 reversion rates are high. Detecting VAPP-related mutations by real-time PCR is rapid and efficient and can be useful in monitoring ongoing global polio eradication efforts.